Matches in Wikidata for { <http://www.wikidata.org/entity/Q94953666> ?p ?o ?g. }
- Q94953666 description "2020 nî lūn-bûn" @default.
- Q94953666 description "2020年の論文" @default.
- Q94953666 description "2020年学术文章" @default.
- Q94953666 description "2020年学术文章" @default.
- Q94953666 description "2020年学术文章" @default.
- Q94953666 description "2020年学术文章" @default.
- Q94953666 description "2020年学术文章" @default.
- Q94953666 description "2020年学术文章" @default.
- Q94953666 description "2020年學術文章" @default.
- Q94953666 description "2020年學術文章" @default.
- Q94953666 description "2020年學術文章" @default.
- Q94953666 description "2020年學術文章" @default.
- Q94953666 description "2020年學術文章" @default.
- Q94953666 description "2020년 논문" @default.
- Q94953666 description "article científic" @default.
- Q94953666 description "article scientific" @default.
- Q94953666 description "article scientifique" @default.
- Q94953666 description "articol științific" @default.
- Q94953666 description "articolo scientifico" @default.
- Q94953666 description "artigo científico" @default.
- Q94953666 description "artigo científico" @default.
- Q94953666 description "artigo científico" @default.
- Q94953666 description "artikel ilmiah" @default.
- Q94953666 description "artikull shkencor" @default.
- Q94953666 description "artikulong pang-agham" @default.
- Q94953666 description "artykuł naukowy" @default.
- Q94953666 description "artículo científico publicado en 2020" @default.
- Q94953666 description "artículu científicu" @default.
- Q94953666 description "bilimsel makale" @default.
- Q94953666 description "bài báo khoa học" @default.
- Q94953666 description "naučni članak" @default.
- Q94953666 description "scienca artikolo" @default.
- Q94953666 description "scientific article published on 13 May 2020" @default.
- Q94953666 description "scientific article published on 13 May 2020" @default.
- Q94953666 description "scientific article published on 13 May 2020" @default.
- Q94953666 description "teaduslik artikkel" @default.
- Q94953666 description "tieteellinen artikkeli" @default.
- Q94953666 description "tudományos cikk" @default.
- Q94953666 description "vedecký článok" @default.
- Q94953666 description "vetenskaplig artikel" @default.
- Q94953666 description "videnskabelig artikel udgivet 13. maj 2020" @default.
- Q94953666 description "vitenskapelig artikkel" @default.
- Q94953666 description "vitskapeleg artikkel" @default.
- Q94953666 description "vědecký článek" @default.
- Q94953666 description "wetenschappelijk artikel" @default.
- Q94953666 description "wissenschaftlicher Artikel" @default.
- Q94953666 description "επιστημονικό άρθρο" @default.
- Q94953666 description "мақолаи илмӣ" @default.
- Q94953666 description "наукова стаття, опублікована в травні 2020" @default.
- Q94953666 description "научна статия" @default.
- Q94953666 description "научная статья" @default.
- Q94953666 description "научни чланак" @default.
- Q94953666 description "научни чланак" @default.
- Q94953666 description "מאמר מדעי" @default.
- Q94953666 description "مقالة علمية نشرت في 13 مايو 2020" @default.
- Q94953666 description "১৩ মে ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q94953666 description "บทความทางวิทยาศาสตร์" @default.
- Q94953666 description "სამეცნიერო სტატია" @default.
- Q94953666 name "Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study" @default.
- Q94953666 name "Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study" @default.
- Q94953666 type Item @default.
- Q94953666 label "Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study" @default.
- Q94953666 label "Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study" @default.
- Q94953666 prefLabel "Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study" @default.
- Q94953666 prefLabel "Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study" @default.
- Q94953666 P1433 Q94953666-A29DC2E2-A4F7-446B-8913-57F8C9ADFDCB @default.
- Q94953666 P1476 Q94953666-1BB560CB-0851-4E7F-B260-20DB88D3D5BA @default.
- Q94953666 P2093 Q94953666-2D448498-B9B3-47E5-AC66-D52081D6F8C6 @default.
- Q94953666 P2093 Q94953666-475378A7-82A3-45C9-B9EE-E4EA283FBE9D @default.
- Q94953666 P2093 Q94953666-98E5A476-8434-4F9F-B435-C78F80F30023 @default.
- Q94953666 P2093 Q94953666-CC07C254-F957-437B-8193-FCBD5010DBF8 @default.
- Q94953666 P2093 Q94953666-E29C0A80-A1F9-4E98-96C1-817EC69F2B88 @default.
- Q94953666 P31 Q94953666-9A3FC33C-AAFC-4A8D-9BD8-F23F1BA8F757 @default.
- Q94953666 P356 Q94953666-537787FE-A67E-43BB-B74C-B396633F7BED @default.
- Q94953666 P50 Q94953666-085F94D6-61CA-4475-A173-3887291E82C8 @default.
- Q94953666 P50 Q94953666-2B40C84A-1418-4BB1-B05E-B35FD2A24887 @default.
- Q94953666 P50 Q94953666-3288B15A-4314-4427-87B3-C5D4A48FF59C @default.
- Q94953666 P50 Q94953666-44D9C067-E100-499D-BAAA-A92E5AF62ABD @default.
- Q94953666 P50 Q94953666-453D2771-4799-4219-A2C4-0DD2F8A3AD02 @default.
- Q94953666 P50 Q94953666-5F09BBE0-0907-45D1-82A7-0695BBB0EBA1 @default.
- Q94953666 P50 Q94953666-6F3D161A-B27A-460A-88E3-768612782A3B @default.
- Q94953666 P50 Q94953666-8071487F-5B81-48D1-BB5D-F8F17280BA69 @default.
- Q94953666 P50 Q94953666-842CF18F-87E5-4105-99FF-A007C16127B4 @default.
- Q94953666 P50 Q94953666-97AFC4A9-6581-45ED-A300-B6FB01B1BC70 @default.
- Q94953666 P50 Q94953666-9B6F7450-2E03-446A-A04D-60D675FFCFDF @default.
- Q94953666 P50 Q94953666-AE2D0253-3BEE-48F8-920A-9C38DF009604 @default.
- Q94953666 P50 Q94953666-B746343C-39A4-492A-84BF-B2D64D60B5AD @default.
- Q94953666 P50 Q94953666-C4DA7D33-B8CC-451C-A5BE-6FC7ED221B44 @default.
- Q94953666 P50 Q94953666-C6C2B91C-EC37-4D48-839D-88D9AB221B8E @default.
- Q94953666 P50 Q94953666-DEE4E207-4588-4C31-9920-42EEB29F8391 @default.
- Q94953666 P577 Q94953666-CD5A1EDC-4089-446D-A78B-E3FC765D691A @default.
- Q94953666 P698 Q94953666-C8EA6C46-3CE2-487C-AC15-E65BCAAE6AF5 @default.
- Q94953666 P921 Q94953666-E6685C75-68A7-44BF-AA19-1746BBBB80C5 @default.
- Q94953666 P356 J.EUO.2020.04.005 @default.
- Q94953666 P698 32417369 @default.
- Q94953666 P1433 Q63882907 @default.
- Q94953666 P1476 "Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study" @default.
- Q94953666 P2093 "Andrea Gallina" @default.
- Q94953666 P2093 "Ewan A Gibb" @default.
- Q94953666 P2093 "Jeffrey S Ross" @default.